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Abstract
Background: Pyrethroids are increasingly used to block the transmission of diseases spread by Aedes aegypti such as
dengue and yellow fever. However, insecticide resistance poses a serious threat, thus there is an urgent need to identify the
genes and proteins associated with pyrethroid resistance in order to produce effective counter measures. In Ae. aegypti,
overexpression of P450s such as the CYP9J32 gene have been linked with pyrethroid resistance. Our aim was to confirm the
role of CYP9J32 and other P450s in insecticide metabolism in order to identify potential diagnostic resistance markers.
Methodology/Principal Findings: We have expressed CYP9J32 in Escherichia coli and show that the enzyme can metabolize
the pyrethroids permethrin and deltamethrin. In addition, three other Ae. aegypti P450s (CYP9J24, CYP9J26, CYP9J28) were
found capable of pyrethroid metabolism, albeit with lower activity. Both Ae. aegypti and Anopheles gambiae P450s (CYP’s
6M2, 6Z2, 6P3) were screened against fluorogenic and luminescent substrates to identify potential diagnostic probes for
P450 activity. Luciferin-PPXE was preferentially metabolised by the three major pyrethroid metabolisers (CYP9J32, CYP6M2
and CYP6P3), identifying a potential diagnostic substrate for these P450s.
Conclusions/Significance: P450s have been identified with the potential to confer pyrethroid resistance in Ae.aegypti.I ti s
recommended that over expression of these enzymes should be monitored as indicators of resistance where pyrethroids are
used.
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Introduction
Dengue fever, transmitted by Aedes mosquito vectors, is a major
public health problem in over 100 countries with some 2.5 billion
people at risk of the disease [1]. Prevention of the disease depends
in large part on vector control, which relies heavily on the use of
insecticides. Interventions are targeted mainly at the larval stage
(larvicides), water source reduction, or spraying with widespread
use of organophosphates such as temephos and pyrethroids such as
deltamethrin. Epidemiologically, however, the adult is the most
important life stage, thus insecticide treated materials (ITMs) that
target this stage have been tested and show promise in reducing
household level dengue vector infestations [2,3,4]. However, since
pyrethroids are the only insecticides approved for use in ITMs [5],
resistance to this insecticide class poses a serious threat to disease
control; indeed, field-based resistance to pyrethroids is rapidly
spreading across most parts of the world [6,7,8,9]. Understanding
resistance mechanisms is essential for the development of new tools
to sustain vector control interventions.
Insecticide resistance in disease vectors is generally attributed to
increased rates of insecticide detoxification or mutations in the
target sites [10]. Due to the large numbers of potential
detoxification genes in the mosquito genome (Aedes aegypti
contains160 P450 genes [11]), detection of metabolism-based
insecticide resistance is more complex than screening for specific
mutations known to cause target site resistance. Nevertheless,
advances in microarray and genome technology have facilitated
transcriptional and genetic comparisons of susceptible and
resistant populations. This has helped identify a number of
P450s that are transcriptionally over-expressed in pyrethroid
resistant populations of Ae. aegypti [11,12,13].
CYP9J32 in particular is a P450 that is found to be strongly
linked to metabolic resistancea si ti ss i g n i f i c a n t l yo v e r -
expressed in pyrethroid resistant strains in widely separated
populations in Vietnam [14], Mexico, Thailand [11] and Brazil
(Strode, unpublished). Microarray screens being done in
Liverpool (Barriami et al submitted) are continuing to indicate
there may be elevated levels of several other P450s in
pyrethroid resistant Ae.aegypti populations including CYP’s
6CB1, 9J10, 9J19, 9J22, 9J24, 9J26 and 9J28. The key question
is whether these P450s are capable of metabolising pyrethroids
and thus functionally linked with insecticide resistance. If so
they may be considered strong markers for existing or incipient
metabolic resistance.
www.plosntds.org 1 March 2012 | Volume 6 | Issue 3 | e1595In general P450s are difficult to produce for in vitro analysis as
they are membrane bound hemoproteins that require electrons
from NADPH P450 oxidoreductase (CPR) and sometimes
cytochrome b5 (b5) for catalysis [15]. However, we recently
optimised the expression of mosquito P450s in E. coli through co-
expression of An. gambiae CPR (AgCPR) and the addition of
exogenous A. gambiae cytochrome b5 (Agb5) [16,17,18], thus
facilitating their functional characterization. We have therefore
adopted this approach for the expression of CYP9J32 and the
other Ae. aegypti P450s implicated in pyrethroid resistance to
investigate their ability to metabolise and thereby contribute
towards insecticide resistance in Ae. aegypti.
Materials and Methods
Reagents
Oligonucleotides were synthesized by Sigma-Aldrich and
enzymes for DNA manipulation were supplied by New England
Biolabs. Isopropyl-ß-D-thio-galactopyranoside (IPTG), 5-aminole-
vulinic acid (ALA), and 3-[(3-cholamidopropyl)-dimethylammo-
nio]-1-propanesulfonate (CHAPS) were supplied by Melford (UK).






panecarboxylate (permethrin, mixture of four isomers), and 2-
isopropoxyphenyl N-methylcarbamate (propoxur). (4S)-4,5-
dihydro-2-(6 9-hydroxy-2 9-benzothiazolyl)-4-thiazolecarboxylic
acid (Beetle luciferin) and proluciferin P450 substrates were
supplied by Promega. HPLC solvents and ethanol were
supplied by Fisher Scientific. Other chemicals were obtained
from Sigma-Aldrich unless indicated otherwise.
Gene cloning
Total RNA was extracted with either the Arcturus PicoPure Kit
(Applied Biosystems) or TRI reagent (Sigma-Aldrich) from ten
adult Ae. aegypti mosquitoes, either ‘‘Isla Mujeres’’ [19] or Merida
strains. Complementary DNA was prepared using Superscript III
(Invitrogen) with an oligo(dT)20 primer and used as a template for
amplifying full-length genes with KOD DNA polymerase (Merk
Chemicals). The gene-specific primers used in these high-fidelity
PCRs were designed according to the Ae.aegypti genome sequence
(Table 1). Amplified genes were ligated into pGEM T-easy
(Promega) and sequenced. For expression, the ompA leader
sequence (ompA), was engineered onto the amino-terminus to
direct the P450 to the E. coli outer membrane during expression.
The ompA-leader was inserted into the expression plasmid
pCWmod1 and linked to the 59-end of the P450 gene with
codons for either: Ala-Pro by blunt ligation via an NaeI site, or
Ala-Gly using cohesive ligation with the isoschizomer NgoMIV.
Both linkers were tested with CYP6CB1 and no difference in
expression quality or quantity was observed. All genes used
cohesive ligation at the 39-end and the restriction enzymes are
indicated in Table 2. Another approach was used for CYP9J19 or
CYP9J26: these genes were prepared with an ompA-Ala-Pro
leader sequence by fusion PCR and cloned into pCW-ori+ using
vector plasmid, pB13 [20] via NdeI and EcoRI sites as previously
described [16].
P450 expression
Competent E. coli DH5a cells were co-transformed with the
pCW- P450 plasmid and and pACYC-AgCPR [16]. Transfor-
mants were selected on Luria-Bertani (LB) agar plates with
50 mg/L ampicilin (pCW-P450 selection) and 34 mg/L chloram-
phenicol (pACYC-AgCPR selection). After overnight growth at
37uC, a single colony was used to inoculate 5 mL of LB with
antibiotics (50 mg/L ampicilin and 34 mg/L chloramphenicol) for
overnight growth at 37uC with shaking. Two mL of this starter
culture was then used to inoculate 200 mL of Terrific Broth with
antibiotics that was then incubated at 37uC with orbital shaking.
Once the cultures had reached early log-phase growth
(A595=0.8–1.0), the culture was cooled to 25uC before adding
1 mM IPTG and 0.5 mM ALA (final concentrations) and
continuing incubation at 25uC with orbital shaking. Initially,
cultures were monitored daily to find the incubation time for
optimal P450 expression: 6CB1, 1 day; 9J19, 2 days; 9J24, 3 days;
9J26, 2 days; 9J28, 2 days; 9J32, 1 day. P450 expression was
estimated by resuspending whole cells in Spectrum Buffer
(100 mM Tris-HCl, pH 7.4, 10 mM CHAPS, 20% (v/v) glycerol,
1 mM EDTA) [20], adding about 1 mg/mL of sodium dithionite
as a reducing agent and recording the absorption spectra (500-
400 nm) change after exposing to CO for 1 min. The peak height
at 450 nm was used to calculate the P450 concentration [21].
Table 1. Accession numbers for P450 clones.
Gene Strain Reference* Clone**
CYP6CB1 Isla Mujeres XM001654530 JF924905
CYP9J10 Isla Mujeres XM001652170 JF924906
CYP9J19 Merida XM001652172 JF924907
CYP9J24 Isla Mujeres XM001649048 JF924908
CYP9J26 Merida XM001649047 JF924909
CYP9J28 Isla Mujeres XM001649045 JF924910
CYP9J32 Isla Mujeres XM001653404 JF924911
*GenBank accession number for the reference genes used in primer design
(Table 2).
**GenBank accession number for the cDNA sequences isolated from the strains
used for this study.
doi:10.1371/journal.pntd.0001595.t001
Author Summary
Dengue fever, transmitted by Aedes mosquito vectors, is a
major public health problem in over 100 countries.
Prevention of the disease relies heavily on the use of
insecticides such as pyrethroids. Unfortunately, mosqui-
toes are becoming resistant to these insecticides so it is
urgent to identify the genes involved to develop an
effective monitoring tool. In insects, P450s are critically
involved in the metabolism and detoxification of insecti-
cides. Several P450s have been found over expressed in
pyrethroid resistant Ae. aegypti, although their functions
are unknown. Here, we have expressed these enzymes in
bacteria and examined their ability to metabolise pyre-
throids and other compounds. From this we have
identified a set of four P450s (CYPs 9J24, 9J26, 9J28 and
9J32) that are involved in pyrethroid metabolism, thus
they may be considered to be key markers of resistance. To
try and track their expression in field populations, we have
developed diagnostic assays to monitor their activity,
which will aid the development of new tools to monitor
resistance and aid disease control.
Pyrethroid Metabolising P450s in Aedes aegypti
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harvested and membranes prepared based on the method by
Pritchard et al. [20]. Immediately after membrane isolated by
ultracentrifugation (1 hr at 180000 g) the sample was homoge-
nized in TSE buffer (50 mM Tris-acetate, pH 7.6, 250 mM
sucrose, 0.25 mM EDTA) using a Dounce homogenizer. Typically
1 mL of TSE was used per 200 mL of culture processed.
The membrane samples were analysed for P450 quality and
content by 100-fold dilution in Spectrum Buffer and CO-
difference spectroscopy [21]. Cytochrome c reductase activity
was used to measure CPR content [22], and protein content was
estimated by Bradford assay. Samples were stored in aliquots at
270uC.
Anopheles gambiae cytochrome b5 was prepared as described
previously [18] .
Insecticide metabolism
5 mM stock concentrations of insecticides were prepared in
ethanol and diluted to 106the assay concentration in 20% (v/v)
ethanol immediately before each experiment to minimise precip-
itation of insecticide. Standard reactions contained a final ethanol
concentration of 2% (v/v) with 10 mM insecticide, 0.1 mM P450,
0.8 mM cyt b5 in 200 mM Tris-HCl for pH 7.4, and NADPH
regeneration components (1 mM glucose-6-phosphate (G6P),
0.25 mM MgCl2, 0.1 mM NADP
+, and 1 U/mL glucose-6-
phosphate dehydrogenase (G6PDH)). Reactions were started, after
pre-incubation at 30uC for 5 min, by adding enzyme samples for a
final reaction volume of 0.1 mL. These were incubated for a
specified time at 30uC with1200 rpm orbitalshaking and quenched
by adding0.1 mL of acetonitrile. Samples were then incubated with
shaking as before for an additional 10 min before centrifuging at
20000 g for 5 min. 0.15 mL of the supernatant was then transferred
to HPLC vials, stored at room temperature and analyzed within
24 hrs.Reactionswere performed intriplicateandapairedT-testof
sample reactions (+NADPH) vs negative control (2NADPH) used
for statistical measurements of substrate depletion.
For enzyme kinetic measurements the reaction rate in response
to insecticide concentration was used to estimate Michaelis-
Menton parameters. Reactions were performed, as described
above, for 10 min with insecticide concentrations of: 0.25, 0.5, 1,
2, 4, 8, or 16 mM. The reactions were performed in parallel
against a negative control (2NADPH) at 16 mM. Non-linear
regression of results of three independent experiments were used
for estimations of KM and kcat (SigmaPlot 11, Systat Software, Inc.).
HPLC analysis
100 ml of acetonitrile-quenched reaction supernatant was
analyzed by reverse-phase HPLC with a 250 mm C18 column
(Acclaim 120, Dionex) and a mobile phase consisting of 90%
acetonitrile and 10% water. The system was run at 23uC with
1 mL/min flow rate. Reactions with with permethrin, deltame-
thrin or DDT, were monitored by absorbance at 232 nm, whereas
imidacloprid or propoxur were monitored at 270 nm. The
insecticide was quantified by peak integration (Chromeleon
software, Dionex). Elution times were 9.2 min for deltamethrin
and 10.1 min for cis- and 11.9 min for trans-permethrin stereoiso-
mers. There was no significant difference in the change of area for
the two permethrin peaks in these reactions, therefore permethrin
concentration was measured as the total area under the two peaks.
Metabolism of probe substrates
Four resorufin ethers were tested as fluorogenic substrates and
six luciferin-based substrates (P450-Glo, Promega) were tested
against each of the Ae.aegypti P450 membrane preps. Three An.
gambiae P450/CYP membrane preps were included for additional
comparisons: CYP6Z2 [16], CYP6P3 [17], and CYP6M2 [18].
Each of these probe substrate were tested in reactions at 25uC
buffered with 0.1 M KPi at pH 7.4 and included: 1 mM G6P,
0.25 mM MgCl2,5mM substrate, 0.1 or 0.2 mM P450, and cyt b5
at twice the P450 concentration. Positive reactions included
0.1 mM NADP and 1 U/mL GADPH whereas negative reactions
had neither of these components and could not generate NADPH.
Table 2. Oligonucleotide sequences used for cloning Ae. aegypti P450 genes.
Target Orientation Feature Sequence, 59 to 39, feature in bold
CYP6CB1 forward ala-pro GCACCAATGTTACTTCCGATCTTACTTGTAG
CYP6CB1 reverse EcoRI CCTTGAATTCACTTTACTTCGTCC
CYP6CB1 forward NgoMIV ATAGCCGGCATGTTACTTCCGATCTTAC
CYP9J10 forward NgoMIV GTAGCCGGCATGGTTGAAGTGGATTTG
CYP9J10 reverse EcoRI TGGAATTCGTTAGACATCTTTTATCAC
CYP9J24 forward NgoMIV GTGGCCGGCATGGAGGTTAATCTGTTCTACTTC
CYP9J24 reverse XbaI TCTCTAGACTACCCCTTTGGTCTTGGCTTG
CYP9J28 forward NgoMIV GGGGCCGGCATGGAGGTTAATCTGTTCTATTTC
CYP9J28 reverse EcoRI CCGAATTCCTACTTCTTAGGTCTAGGTTTGAAC
CYP9J32 forward NgoMIV GTAGCCGGCATGGAGGTGAACCTGCTTTTATTAC
CYP9J32 reverse XbaI CTTCTAGATCACTTCCTCTTCTTAAATCTCAAATG
CYP9J19 forward ala-pro GCACCGATGGAAGTGGATCTCCTCTCG
CYP9J19 reverse EcoRI GAATTCTACGGTATGTTAACAATCTTAAG
cyp9j19 reverse ompA-ala-pro GAGAGGAGATCCACTTCCATCGGTGCGGCCTGCGCTAC
cyp9j26 forward ala-pro GCACCAATGGAAGTGGAACTCCTACATGTG
cyp9j26 reverse EcoRI site GAATTCACCGCAGCTTCAGCTCC
cyp9j26 reverse ompA-ala-pro CATGTAGGAGTTCCACTTCCATTGGTGCGGCCTGCGCTAC
doi:10.1371/journal.pntd.0001595.t002
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triplicate. Luciferin (Promega) or resorufin standard curves were
analyzed with each 96-well plate and used to calculate product
formation rate.
Resorufin-producing reactions were monitored in a fluorescence
plate-reader (Ex=565 nm, Em=585 nm) with 200 ms measure-
ments recorded 24 s apart. The rate of resorufin molecules
produced per P450 molecule per min (turnover) was determined
by linear regression of the measurements between 2 min and
8 min after the reactions began. Luciferin reactions were run for
30 min before quenching as described by the P450-Glo kit . The
endpoint signal was then measured by a luminescence plate-reader
and the turnover calculated. Three replicates of positive and
negative control reactions were run for each P450/substrate
combination. Significant differences were determined by one-
tailed T-tests (assuming equal variances).
Results
Expression of Ae. aegypti P450s in E. coli
To produce a catalytically active monooxygenase complex
CYP’s 6CB1, 9J10, 9J19, 9J24, 9J26, 9J28 and 9J32 were co-
expressed with An. gambiae CPR in E. coli membranes [16]. As
previously, An. gambiae b5 was also used to enhance P450 catalytic
activity [23]; An. gambiae CPR and b5 are extremely similar to their
Ae. aegypti homologues sharing 87% and 84% amino acid identity
respectively, thus capable of reconstituting Aedes P450 activity.
Apart from CYP9J10, which repeatedly failed to express
functional enzyme in E. coli, all P450s produced the characteristic
CO-reduced spectra indicative of active P450 (Figure 1). Apart
from CYP6CB1 all P450s contained very low quantities of inactive
P420 and high levels of P450 up to ,200 nmol/L for CYP9J19
(Table 3). CYP6CB1 produced relatively low quantities of P450
(,10 nmol/L; Table 3) and large amounts of P420, suggestive of
poor enzyme quality.
Insecticide metabolism
In order to determine if the P450s were capable of pyrethroid
metabolism, they were tested against permethrin and deltame-
thrin, representative Type I (non-cyano) and Type II (cyano)
pyrethroids respectively. Catalytic activity was assessed by
measuring substrate turnover (disappearance of substrate with
time)(Figure 2). CYP’s 9J24, 9J26, 9J28 produced low, but
reproducible deltamethrin and permethrin turnover, whereas
CYP9J32 demonstrated strong activity for deltamethrin and weak
activity for permethrin (Figure 2). CYP’s 9J19 and 6CB1 did not
Figure 1. Carbon monoxide difference spectra of bacterial membranes expressing Ae.aegypti P450s. (A), CYP6CB1; (B), CYP9J26; (C),
CYP9J32 ; (D), CYP9J24; (E), CYP9J28; and (F), CYP9J19.
doi:10.1371/journal.pntd.0001595.g001
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9J26, 9J28 and 9J32 to metabolise pyrethroids was further
characterised by measuring substrate dependent reaction rates.
The reactions followed Michaelis-Menten kinetics and the kinetic
constants were estimated for each P450-pyrethroid combination
(Table 4). The apparent KM measurements for permethrin ranged
from 2.361.1 mM (CYP9J32) to 4.260.9 mM (CYP9J26) and for
deltamethrin from 1.260.2 mM for (CYP9J26) to 5.262.1 mM
(CYP9J32). The turnover rates (kcat) for permethrin ranged from
0.1660.03 min
21 (CYP9J24) to 0.860.1 min
21 (CYP9J32) and
from 0.2260.02 min
21 (CYP9J26 or CYP9J28) to 3.060.5 min
21
(CYP9J32) for deltamethrin. Overall, the KM values for all P450s
were within the normal range, 1–50 mM, associated with substrate
binding and P450 metabolism [18,24]. In comparison with the
normal broad range of kcat values for P450s of 1–20 min
21, kcat
values were low i.e. ,1 min
21. The exception was CYP9J32,
which had a high kcat value of ,3 min
21 for deltamethrin.
Interestingly the kcat for permethrin was ,3 fold lower
(0.8 min
21). Finally, as for the pyrethroids, all P450s where tested
against DDT (organochlorine), propoxur (carbamate), and imida-
cloprid (neonicotinoid), but there was no obvious substrate
turnover detected.
Probe substrate metabolism
Fluorescent and chemiluminescent substrates are routinely used
in the pharmaceutical industry for monitoring P450 activity [25].
In the context of vector control these probes could be extremely
useful for diagnostic monitoring of P450 levels for insecticide
resistance [26]. We therefore screened the Ae. aegypti P450s for
their ability to metabolise the four fluorogenic resorufin ethers;
methyl (RME), ethyl (REE), pentyl (RPE), or benzyl ethers (RBE),
as well as six P450 Glo
TM proluciferin substrates, L-H, L-ME, L-
CEE, L-BE, L-PFBE, L-PPXE. However, with the exception of
CYP9J32, which produced a high rate of metabolism with the
Table 3. Yields of Ae.aegypti P450s expressed in E. coli.
P450 N







CYP6CB1 3 10670 . 1 60.1 37624
CYP9J10 3 0 0 102
CYP9J19 1 186 1.56 32
CYP9J24 3 29680 . 6 60.3 93635
CYP9J26 2 25, 5 0.3, 0.1 45, 32
CYP9J28 3 47630 1.160.9 157665
CYP9J32 4 83628 0.960.3 142614
aNumber of independent membranes used for yield calculations.
Measurements are expressed as means 6 standard deviation. Where N,3,
individual measurements are listed.
bnmol of P450 isolated in membrane preparation per litre of bacterial cultures.
cP450 concentration in membrane preparations as nmol of P450 per mg of total
protein.
dCPR activity in membrane preparation measured as nmol of cytochrome c
reduced per min per mg of total protein.
doi:10.1371/journal.pntd.0001595.t003
Figure 2. Permethrin and deltamethrin metabolism by Ae aegypti P450s. The proportion of 10 mM insecticide cleared by 0.1 mM P450 with
0.8 mM cyt b5 in the presence of NADPH is indicated by bar height. Error bars represent standard deviation (N=3) and significantly greater insecticide
clearance compared to negative reactions (no NADPH supplied) are indicated: *P,0.05, **P,0.01, or ***P,0.001 (paired T-test).
doi:10.1371/journal.pntd.0001595.g002
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unreactive against these substrates (Figure 3).
We extended the screen to include three An. gambiae P450s
namely, CYP6P3 [17] and CYP6M2 [18], which metabolise
pyrethroids and CYP6Z2, which does not metabolise pyrethroids
[16]. Like CYP9J32, CYP6P3 and CYP6M2 showed a clear
preference for the luciferin substrate L-PPXE. In contrast,
CYP6Z2 showed a marked preference for the smaller probe
substrates with the greatest activity towards RME for the resorufin
ethers and L-ME for the proluciferins (Figure 3).
Discussion
Over the past few years the widespread use of organophosphates
and synthetic pyrethroids for the control of Ae. aegypti larvae and
adults has fed the emergence of insecticide resistance in many
dengue endemic countries [27,28,29]. CYP9J32 has been found
over-expressed in deltamethrin and permethrin resistant Ae aegypti
strains in Thailand, Mexico and Vietnam [11,14]. Here we have
demonstrated that CYP9J32 can metabolise both these pyre-
throids. Although the production of more toxic products cannot be
ruled out, P450 metabolism generally results in the production of
less toxic, more excretable, hydroxylated metabolites and/or
degradation products [18]. Thus, high levels of expression of
CYP9J32 found in resistant populations of Ae. aegypti [11,14] are
indicative of a chemoprotective role for CYP9J32.
In the context of dengue control operations, CYP9J32 therefore
represents a strong candidate for predicting metabolic resistance in
Ae. aegypti, particularly in Vietnam where CYP9J32 was the only
P450 significantly over-expressed in the highly deltamethrin
resistant Nha Trang strain [14]. The turnover for deltamethrin
was in the turnover range 1–5 min
21 found for other deltamethrin
metabolising P450s CYP6P3 and CYP6M2 from An. gambiae
[18,30]. Indeed, considering the high deltamethrin resistance of
this strain, what is most striking about the biochemical data is the
Table 4. Subsrate-saturation kinetic constants.
KM (mM) Kcat (min
21)
P450 Permethrin Deltamethrin Permethrin Deltamethrin
CYP9J32 2.361.1 5.262.1 0.860.1 3.060.5
CYP9J28 2.660.4 1.760.5 0.4460.03 0.2260.02
CYP9J26 4.260.9 1.260.2 0.660.1 0.2260.01
CYP9J24 3.361.6 2.961.5 0.1660.03 0.3160.06
doi:10.1371/journal.pntd.0001595.t004
Figure 3. Metabolism of probe substrates by Ae. aegypti and An. gambiae P450s. Solid bars indicate significant turnover of probe substrates
compared to the negative (2NADPH) control reactions (N=3, T-test). The chemical structures of the resorufin and lucerifin-based probe substrates
are shown below the X-axis.
doi:10.1371/journal.pntd.0001595.g003
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min
21 ) relative to permethrin (kcat=0.8 min
21).
While there have been a number of studies investigating
insecticide resistance in different populations of Ae. aegypti
[8,9,14,19,28,31], it is clear that a single metabolic gene does
not confer resistance in this species, unlike target site resistance.
Instead, given the multiplicity of detoxification genes and their
overlapping substrate specificities, numerous combinations of
detoxifying enzymes may give rise to insecticide resistance [14].
Thus it is not surprising that along with CYP9J32, our data reveals
at least three other Ae. aegypti P450s that are capable of
metabolising the pyrethroid insecticides permethrin and deltame-
thrin, CYP9J24, CYP9J26, CYP9J28. Most significantly,
CYP9J26 and CYP9J28 P450s are found over-transcribed in
deltamethrin resistant field populations in both Cayman Islands
and Cuba (Bariami et al, submitted), emphasizing a potentially
important role in pyrethroid clearance in-vivo. Therefore, elevated
levels of these P450s are a strong indicator for resistance to
pyrethroids, and an important consideration for planning
successful interventions [5].
At present, the identification of metabolism – based insecticide
resistance generally relies on the detection of gene over-expression,
which is more subjective and less accurate than identifying specific
target site mutations such as kdr, which can be done by PCR [32].
Thus biochemical assays for detecting metabolic resistance by
P450s are in general use [33], although they usually employ
generic heme peroxidase assays that are recognised by many
members of the enzyme family [7], compromising sensitivity and
specificity. Having produced a panel of recombinant mosquito
P450s associated with pyrethroid resistance we screened them
against available fluorescent resorufin compounds and luminescent
luciferin-based substrates to try and identify more specific probes
for resistance monitoring. The luciferin substrate L-H has been
used for tracking general P450 activity in the mosquito Culex pipiens
[26]. Thus it was surprising that L-H proved to be such a poor
substrate against the panel of individual mosquito P450s (Fig. 3).
Instead, the three major pyrethroid metabolisers, CYP9J32,
CYP6P3 and CYP6M2, metabolised L-PPXE (Figure 3). L-PPXE
contains a noticeably large aromatic group linked to the luciferin
moiety, possibly more reflective of a pyrethroid-like substrate.
Consistent with their low permethrin and deltamethrin activity, it
is notable that the other pyrethroid metabolisers CYP’s 9J24, 9J26
and 9J28 produced low levels of PPXE activity. Given the high
activity of CYP9J32 for L-PPXE this suggests that this may be a
very good substrate for tracking this and potentially other
pyrethroid metabolising P450s. Such an assay, requiring individual
or pooled mosquito homogenates, is potentially relatively high
throughgput (96 well plate) and rapid (20–30 min for enzyme
reaction time), although capital expense may be a limiting factor
given the high cost of luminescence detectors.
Finally, although we have not yet examined the active site
structure of CYP9J32, it is worth noting that several structural
models of pyrethroid metabolising mosquito P450s have been
produced including CYP6M2 [18] from An. gambiae and
CYP6AA3 and CYP6P7 from An. minimus [34,35,36]. These
provide an important reference point for further studies into the
mechanisms of pyrethroid metabolism by mosquito P450s.
In conclusion, we have characterised several P450s associated
with insecticide resistance in Ae. aegypti and identified four (CYP’s
9J32, 9J24, 9J26 and 9J28) that are capable of metabolising
deltamethrin and permethrin, two of the commonest pyrethroids
used by vector control operations. Given the escalating use of
microarray and PCR-based technology for resistance monitoring
[5], elevated levels of expression of these P450s should be
considered a warning of incipient or existing metabolic resistance.
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